Skip to content Skip to navigation

Senators Request Clarity on mHealth App Regulation from FDA

March 19, 2014
by Gabriel Perna
| Reprints

A group of U.S. Senators have sent a letter to Food and Drug Administration (FDA) Commissioner, Margaret A. Hamburg, M.D. seeking further clarity and transparency on how the agency plans on regulating medical mobile health (mHealth) apps.

Senators Michael Bennet (D-Colo.), Orrin Hatch (R-Utah), Tom Harkin (D-Iowa), Lamar Alexander (R-Tenn), Mark Warner (D-Va), and Richard Burr (R-NC) sent the letter to Dr. Hamburg, asking for further clarification  for medical software application developers. Referring to the FDA's final guidance over mHealth apps, the Senators note that the agency used a risk-based approach in defining what it considers to be a mobile medical application, focused on high-risk medical software in particular. The Senators say a large number of apps could be actively regulated under this definition and more transparency is required for developers.

"While the FDA’s final guidance has provided clarity on the agency’s approach to regulation of mobile medical applications, we believe more transparency is needed to avoid stakeholder confusion over how a wider range of medical software might be appropriately regulated," the Senators wrote in the letter.

The Senators include a series of questions within the letter that it requests the FDA answer within three weeks of its receipt. Some of those questions include:

  • Compared to current FDA guidance, what impact would Congress establishing categories of medical software in legislation have on the FDA’s oversight of medical mobile applications?
  • What role, if any, can statutory definitions play to clarify any uncertainty with respect to assigning risk level to medical software?

  • How is the FDA determining what types of medical software updates, even minor updates, change the function of or add a function to the medical software and would require FDA review?

  • How has the FDA been coordinating with the Office of the National Coordinator and Federal Communications Commission to address the recent FDA Safety and Innovation Act working group’s concerns over interoperability?

The letter, in its entirety, can be read by clicking the link below.

 

Read the source article at Michael Bennet

Topics

News

CMS Extends Deadline for eCQM Data Submission

CMS is extending the deadline for eligible hospitals in the Hospital Inpatient Quality Reporting (IQR) and Meaningful Use programs to submit their electronic clinical quality measure (eCQM) data from 2016.

NorthShore Revalidated by HIMSS Analytics as Stage 7 Worthy

Due to its continued use of IT to improve patient care and reduce costs, Chicago-based NorthShore University HealthSystem has received Stage 7 revalidation on HIMSS’ acute care EMRAM and outpatient EMRAM for its hospitals and associated clinics.

Cybersecurity Consulting Firm CynergisTek Acquired by Auxilio

Austin, Tex.-based cybersecurity and privacy consulting firm CynergisTek has been acquired by Auxilio, Inc., a provider of document workflow solutions and IT security services based in Mission Viejo, California, in a deal valued at up to $34.3 million.

Healthcare Data Breaches: A Year in Review

The latest year-in-review Breach Barometer report from Protenus paints a stark picture—2016 average at least one health data breach per day, affecting more than 27 million patient records.

Healthcare Industry Could Save $9.4B with Full Adoption of Electronic Transactions

The healthcare industry continues to make modest progress toward full adoption of electronic business transactions, but significant gaps remain, representing an opportunity for $9.4 billion in savings, according to new data from the 2016 CAQH Index.

ONC Announces Phase 2 Winners of Consumer, Provider App Challenges

ONC today announced the Phase 2 winners for the Consumer Health Data Aggregator Challenge and the Provider User Experience Challenge.